Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a global mRNA medicines and vaccines company with enabling technologies, including LUNAR® lipid-mediated delivery and STARR® mRNA Technology. Arcturus developed the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine and has a robust pipeline of RNA therapeutic candidates and partnered mRNA vaccine programs.
